NCT02330913

Brief Summary

Laparoscopic gastrectomy became a good option for early gastric cancer. Surgical trend is gradually changed to totally laparoscopic gastrectomy from laparoscopy-assisted gastrectomy requiring mini-laparotomy. Various types of intracorporeal anastomosis have been introduced for esophagojejunostomy during total gastrectomy. We invented a novel anastomosis method using linear stapler for total gastrectomy. Three procedures (Jejunal resection, esophageal resection and closure of common entry hole after anastomosis) was performed with only one stapler. Therefore, the novel method is simple and fast. Also, this new technique is better economically than previously introduced anastomosis using linear stapler because lesser number of stapler is required. We want to demonstrate the feasibility of novel intracorporeal anastomosis method during laparoscopic total gastrectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable gastric-cancer

Timeline
Completed

Started Dec 2014

Shorter than P25 for not_applicable gastric-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 19, 2014

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 5, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

December 29, 2015

Status Verified

December 1, 2015

Enrollment Period

10 months

First QC Date

December 19, 2014

Last Update Submit

December 24, 2015

Conditions

Keywords

total gastrectomyintracorporealtotally laparoscopicesophagojejunostomyanastomosis

Outcome Measures

Primary Outcomes (1)

  • Anastomosis related complication rate

    Anastomotic leakage, intraluminal bleeding, or stenosis were considered as anastomosis related complication

    During 30 days after operation

Study Arms (1)

Intracorporeal esophagojejunostomy

EXPERIMENTAL

Patient group with intracorporeal esophagojejunostomy with linear stapler

Procedure: Intracorporeal esophagojejunostomy

Interventions

Under laparoscopic view, esophagojejunostomy was pereformed with 60mm linear stapler on right side of distal esophagus like as functional end-to-end fashion before esophageal and jejunal resection. Then, three procedures of esophageal resection, common entry hole closure and jejunal resection was performed with a single use of 60mm stapler. Also, jejunojejunostomy was also performed via already made staple entry hole.

Intracorporeal esophagojejunostomy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically confirmed adenocarcinoma in stomach
  • Males or Females, aged≥20 years and ≤80 years
  • Without serosa invasion, extraperigastric lymph node metastasis and other organ metastasis stage in preoperative evaluation, (cT1-3N0-1M0)
  • Beyond the indication of ESD
  • Tumor location in high body of stomach or requiring total gastrectomy
  • Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1 at study entry
  • American Society of Anesthesiolosists (ASA) score of 1 to 3
  • The patient has given their written informed consent to participate in the study

You may not qualify if:

  • Simultaneous malignancy in other organ
  • Experience of previous laparotomy
  • Experience of gastric resection including wedge resection
  • Vulnerable subject

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keimyung University Dongsan Medical Center

Daegu, 700-712, South Korea

Location

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Officials

  • Seung Wan Ryu, Ph.D.

    Keimyung University Dongsan Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Gastrointesinal surgery, associate professor

Study Record Dates

First Submitted

December 19, 2014

First Posted

January 5, 2015

Study Start

December 1, 2014

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

December 29, 2015

Record last verified: 2015-12

Locations